fda banned tirzepatide Ban on Compounded GLP-1 Drugs: What to Know FDA Drug Recalls and Warnings:

That is a pretty impressive response that you wont get from taking a GLP-1 injectable

MASH confers excess risk not only for cardiovascular disease but also for chronic kidney disease (CKD) and several extra-hepatic malignancies [56, 57]

In conclusion, we found tirzepatide was an effective therapy with significant benefits on glycemic control, blood pressure, total cholesterol, and weight in subjects with diabetes and chronic kidney disease treated at a tertiary care facility

Ibrahim et al., 2008)

Consistency helps your body maintain stable medication levels

GLP-1 has another beneficial effect in type 2 diabetes that contributes to maintaining euglycaemia: in type 2 diabetes glucagon secretion is excessively stimulated and glucagon stimulates hepatic glucose production